PALO ALTO, Calif. -- (BUSINESS WIRE) -- Theranos, Inc. today announced the appointment of William H. Foege, M.D., M.P.H., to its Board of Directors.
Dr. Foege, an epidemiologist and former director of the U.S. Center for Disease Control and Prevention (CDC), has left an indelible mark on the field of global health. Recognized as the health innovator behind the successful campaign to eradicate smallpox in the 1970s, Dr. Foege received the Presidential Medal of Freedom in 2012, the nation’s highest civilian honor. He was a senior medical advisor for the Bill and Melinda Gates Foundation from 1999 until his retirement in 2011.
“We are proud to have Bill join our team in our mission to make actionable health information accessible to everyone at the time it matters most,” said Elizabeth Holmes, Theranos’ founder and CEO. Holmes added, "We believe access to affordable, real-time diagnostic information is a basic human right. As we grow, we are working to make it possible for every person to be able to afford and access diagnostic tests with very small amounts of sample and in locations through which testing was previously not accessible."
“The application of nanotechnology to laboratory diagnosis has the potential to change health care delivery while reducing costs. It is particularly exciting to consider the possibilities for revolutionizing the ability to diagnose illnesses in resource-poor areas of the world,” said Dr. Foege.
After heading the Smallpox Eradication Program at the CDC, Dr. Foege was appointed director in 1977. In 1984, he co-founded the Task Force for Child Survival, a working group for WHO, UNICEF, The World Bank, United Nations Development Program, and the Rockefeller Foundation. Its success in accelerating childhood immunization led to an expansion of its mandate to address other issues that diminish the quality of life for children.
Dr. Foege joined The Carter Center in 1986 as executive director, fellow for health policy, and executive director of Global 2000. He later contributed to the Center's work as a fellow and as executive director of the Task Force for Child Survival and Development. In 1997, he joined Emory University’s faculty where he is now Emeritus Presidential Distinguished Professor of International Health. Dr. Foege is also a senior fellow in the Global Health Program for the Bill and Melinda Gates Foundation.
Dr. Foege joins existing Theranos Board members Elizabeth Holmes, Theranos Chairman and Chief Executive Officer; George P. Shultz; Gary Roughead; William J. Perry; Samuel Nunn; James Mattis; Richard Kovacevich; Henry A. Kissinger; William H. Frist; Riley P. Bechtel; and Sunny Balwani, Theranos President and Chief Operating Officer.
Headquartered in Palo Alto, Theranos, Inc. is a consumer healthcare technology company. Theranos’ clinical laboratory offers comprehensive laboratory tests from samples as small as a few drops of blood at unprecedented low prices. Founded in 2003 by Elizabeth Holmes, Theranos’ mission is to make actionable health information accessible to people everywhere in the world at the time it matters, enabling early detection and intervention of disease, and empowering individuals with information to live the lives they want to live. www.theranos.com